TW200509964A - VP1 of foot-and-mouth disease virus - Google Patents

VP1 of foot-and-mouth disease virus

Info

Publication number
TW200509964A
TW200509964A TW093114903A TW93114903A TW200509964A TW 200509964 A TW200509964 A TW 200509964A TW 093114903 A TW093114903 A TW 093114903A TW 93114903 A TW93114903 A TW 93114903A TW 200509964 A TW200509964 A TW 200509964A
Authority
TW
Taiwan
Prior art keywords
foot
disease virus
mouth disease
polypeptide
monomers
Prior art date
Application number
TW093114903A
Other languages
English (en)
Other versions
TWI285111B (en
Inventor
Shu-Mei Liang
Jeng-Hwan Wang
Jeng-Jer Shieh
Original Assignee
Academia Sinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academia Sinica filed Critical Academia Sinica
Publication of TW200509964A publication Critical patent/TW200509964A/zh
Application granted granted Critical
Publication of TWI285111B publication Critical patent/TWI285111B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
TW093114903A 2003-05-29 2004-05-26 VP1 of foot-and-mouth disease virus TWI285111B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/449,531 US7217784B2 (en) 2003-05-29 2003-05-29 VP1 of foot-and-mouth disease virus

Publications (2)

Publication Number Publication Date
TW200509964A true TW200509964A (en) 2005-03-16
TWI285111B TWI285111B (en) 2007-08-11

Family

ID=33451806

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093114903A TWI285111B (en) 2003-05-29 2004-05-26 VP1 of foot-and-mouth disease virus

Country Status (2)

Country Link
US (2) US7217784B2 (zh)
TW (1) TWI285111B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323546B2 (en) * 2003-05-29 2008-01-29 Academia Sinica Apoptosis-inducing polypeptides
CN101121938B (zh) * 2007-03-23 2010-10-06 中国农业科学院兰州兽医研究所 一种口蹄疫抗原的制备方法
WO2009114831A2 (en) 2008-03-13 2009-09-17 Academia Sinica Process to produce fibrillar proteins and method of treating using fibrillar proteins
WO2011017835A1 (en) * 2009-08-11 2011-02-17 Nanjing University Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding
CN103202812B (zh) * 2010-08-09 2015-10-28 南京大学 一种制备用于体内递送药理活性物质的蛋白纳米粒的方法
CN103202813B (zh) * 2010-08-09 2015-09-30 南京大学 一种制备用于体内递送药理活性物质的蛋白纳米粒的方法
US8795678B2 (en) 2011-05-13 2014-08-05 Academia Sinica TLR-2 agonists and methods of use thereof
CN103864905B (zh) * 2013-12-30 2016-02-17 大连大学 一种o型口蹄疫ctl表位肽及筛选方法
CN111803626A (zh) * 2020-07-08 2020-10-23 申联生物医药（上海）股份有限公司 猪口蹄疫o型和a型二价合成肽疫苗及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4769237A (en) * 1983-03-25 1988-09-06 Bittle James L Synthetic picornavirus antigen

Also Published As

Publication number Publication date
US7217784B2 (en) 2007-05-15
US20080199911A1 (en) 2008-08-21
US7604961B2 (en) 2009-10-20
TWI285111B (en) 2007-08-11
US20040242458A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
WO2004014418A3 (en) Neisserial vaccine compositions comprising a combination of antigens
EP1504112A4 (en) DEVELOPMENT OF A VACCINE FOR THE PREVENTION OF INFECTIONS WITH THE FILOVIRUS IN PRIMATES
EP1200109A4 (en) USE OF PEPTIDE NUCLEIC ACID COMPOUNDS TO TRIGGER CELLULAR IMMUNE RESPONSES TO HEPATITIS C
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
AP1872A (en) Virus-like particles of human papillomavirus.
NO20052136L (no) Vaksine mot Hepatitt C-virus (HCV).
WO2006044923A3 (en) Yeast-based therapeutic for chronic hepatitis c infection
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
CA2505942A1 (en) West nile virus vaccine
WO2006073431A3 (en) Avipox recombinants expressing foot and mouth disease virus genes
WO2004085633A8 (en) A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
ECSP024257A (es) Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas
WO2005035558A3 (en) Piscirickettsia salmonis antigens and use thereof
TW200509964A (en) VP1 of foot-and-mouth disease virus
ATE465753T1 (de) Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden
GB2429711A (en) Heart and skeletal muscle inflammation (HSMI) virus
DK1290160T3 (da) Humane Pellino-polypeptider
WO2006024240A3 (es) Composición vacunal contra el virus de la hepatitis c.
MXPA03009763A (es) Vacuna contra el virus de la enfermedad de la fiebre aftosa.
EP1438066A4 (en) IMMUNOGENIC COMPOSITIONS OF ENTIRE CELLS OF REACTIVE BACTERIA
HK1082666A1 (en) Ihnv g fusion protein for immune stimulation
EP1439856A4 (en) RECOMBINANT TOLLWOOD VACCINES AND METHOD FOR THEIR PREPARATION AND USE
EP1427443A4 (en) VACCINE USING VIRUS VIRUS-ADJUSTED PAPILLOMA VIRUS PROTEINS
MY127452A (en) Vaccines.
AU2018200081B2 (en) Avirulent, immunogenic flavivirus chimeras